We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Read MoreHide Full Article
The most recent trading session ended with UnitedHealth Group (UNH - Free Report) standing at $298.17, reflecting a +0.02% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 0.4%. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq gained 0.39%.
Coming into today, shares of the largest U.S. health insurer had lost 27.55% in the past month. In that same time, the Medical sector lost 3.41%, while the S&P 500 gained 6.69%.
The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. On that day, UnitedHealth Group is projected to report earnings of $5.47 per share, which would represent a year-over-year decline of 19.56%. Simultaneously, our latest consensus estimate expects the revenue to be $112.14 billion, showing a 13.44% escalation compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $23.38 per share and revenue of $451.8 billion, indicating changes of -15.47% and +12.87%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 13.7% lower. Right now, UnitedHealth Group possesses a Zacks Rank of #5 (Strong Sell).
In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 12.75. This signifies no noticeable deviation in comparison to the average Forward P/E of 12.75 for its industry.
Also, we should mention that UNH has a PEG ratio of 1.17. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - HMOs was holding an average PEG ratio of 0.97 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 89, which puts it in the top 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The most recent trading session ended with UnitedHealth Group (UNH - Free Report) standing at $298.17, reflecting a +0.02% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 0.4%. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq gained 0.39%.
Coming into today, shares of the largest U.S. health insurer had lost 27.55% in the past month. In that same time, the Medical sector lost 3.41%, while the S&P 500 gained 6.69%.
The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. On that day, UnitedHealth Group is projected to report earnings of $5.47 per share, which would represent a year-over-year decline of 19.56%. Simultaneously, our latest consensus estimate expects the revenue to be $112.14 billion, showing a 13.44% escalation compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $23.38 per share and revenue of $451.8 billion, indicating changes of -15.47% and +12.87%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 13.7% lower. Right now, UnitedHealth Group possesses a Zacks Rank of #5 (Strong Sell).
In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 12.75. This signifies no noticeable deviation in comparison to the average Forward P/E of 12.75 for its industry.
Also, we should mention that UNH has a PEG ratio of 1.17. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - HMOs was holding an average PEG ratio of 0.97 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 89, which puts it in the top 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.